8-Year Study on 5-Session Prostate Treatment
A study published after 8 years revealed that high-dose radiation therapy, known as SBRT, is an effective option for patients with low to intermediate-risk prostate cancer—especially when administered in just five sessions without hormone therapy. The research showed that the disease-free survival rate was up to 91% after five years, with reports of better urinary control and improved sexual function compared to surgery, despite some mild bowel issues. This treatment is considered less invasive and is preferred in certain cases; however, the choice of therapy depends on individual factors such as tumor risk level and the patient's overall health. It is advisable to discuss these options with a doctor to determine the most suitable approach.
Notice: This Is an AI-Generated Summary
Comments (0)